Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: A multicentre, phase 1/2, open-label, dose-escalation study

Irene M. Ghobrial, Edie Weller, Ravi Vij, Nikhil C. Munshi, Ranjit Banwait, Meghan Bagshaw, Robert Schlossman, Renee Leduc, Stacey Chuma, Janet Kunsman, Jacob Laubach, Andrzej J. Jakubowiak, Patricia Maiso, Aldo Roccaro, Philippe Armand, Akari Dollard, Diane Warren, Brianna Harris, Tiffany Poon, Amy SamScott Rodig, Kenneth C. Anderson, Paul G. Richardson

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: A multicentre, phase 1/2, open-label, dose-escalation study'. Together they form a unique fingerprint.

Medicine & Life Sciences